Australia to Continue AstraZeneca Covid-19 Vaccination Despite Blood Clotting Case2Photo© news18.com

Australia to Continue AstraZeneca Covid-19 Vaccination Despite Blood Clotting Case

, 16 news, a view

Australia will continue its inoculation programme with AstraZeneca PLC, health officials said on Saturday, after a blood clotting case raised concern about the safety of the vaccine.

A 44-year-old man was admitted to a Melbourne hospital with clotting, days after receiving the AstraZeneca vaccine, suffering serious thrombosis, a condition that prevents normal blood flow though the circulatory system.

The Therapeutic Goods Administration (TGA) regulator and a panel, the Australian Technical Advisory Group on Immunisation (ATAGI), met late Friday and early Saturday to discuss further advice on the AstraZeneca vaccine.